RELX International Partners with Philippine Government to Regulate E-cigarette Sales

News by Alice Wang
Jun.14.2023
RELX International Partners with Philippine Government to Regulate E-cigarette Sales
RELX International partners with Philippine Department of Trade and Industry (DTI) to regulate e-cigarette sales. They supports crackdown on illegal products and prioritizes consumer safety.

On June 13th, RELX International (RLX) announced that it will be partnering with the Philippine Department of Trade and Industry (DTI) to strengthen regulations on the sales of e-cigarette products.

 

Patrick C. Drilon, the external affairs manager of RLX in the Philippines, stated in a declaration that,

 

"We will closely collaborate with the Department of Trade and Industry in the Philippines to investigate and address any unlawful actions of e-cigarette product sellers."

 

Previously, Alfredo Pascual, the Secretary of the Philippines' Department of Trade and Industry, issued a directive to strictly monitor the sales of e-cigarette products to ensure compliance with the regulations of the Vaporized Nicotine and Non-Nicotine Product Regulation Act.

 

This law establishes guidelines and restrictions for the sale and distribution of e-cigarette products in the Philippines.

 

Mr. Drilon said:

 

RLX fully supports the efforts of government departments to enforce sales regulations and is taking necessary actions to crackdown on any violations.

 

Earlier, the Philippine Department of Trade and Industry announced that they have seized 13,784 e-cigarette products worth 4.25 million pesos (about 550,000 RMB) from non-compliant e-cigarette stores and issued violation notices to 72 companies.

 

The Ministry of Commerce and Industry stated that most of the violations are related to product packaging requirements, sales of e-cigarettes or new tobacco products containing nicotine or non-nicotine, restrictions on product promotion, advertising and sponsorship, and the ban on the use of nicotine and non-nicotine products in public places.

 

Mr. Delilong stated that RLX supports DTI's efforts to combat illegal e-cigarette products and emphasized that consumer safety is the company's top priority.

 

References:

 

RELX has announced that it will collaborate closely with the Department of Trade and Industry (DTI) to impose stricter regulations on the sale of vape products.

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Michigan Governor budget to seek major tax hikes on tobacco, vaping and gaming to address Medicaid gap
Michigan Governor budget to seek major tax hikes on tobacco, vaping and gaming to address Medicaid gap
Governor Gretchen Whitmer’s proposed fiscal year 2027 budget includes significant tax hikes on tobacco and gaming to address a projected $1.8 billion shortfall in Michigan’s Medicaid funding, the report said. The plan calls for raising the per-pack cigarette tax from $2 to $3 and increasing the wholesale tax on other tobacco products from 32% to 57%.
Feb.12 by 2FIRSTS.ai
Philip Morris Ukraine Says Ukraine’s Flavored Vape Ban Still Lacks Effective Enforcement
Philip Morris Ukraine Says Ukraine’s Flavored Vape Ban Still Lacks Effective Enforcement
Mikhail Polyakov, deputy general director for corporate affairs at Philip Morris Ukraine, said Ukraine’s ban on flavored and aromatic additives for e-cigarettes, in force since July 11, 2024, has not worked in practice because compliance is not being enforced.
Mar.17 by 2FIRSTS.ai
Arizona Lawmaker Pushes Alternative Nicotine Product Bill as Enforcement Concerns Emerge
Arizona Lawmaker Pushes Alternative Nicotine Product Bill as Enforcement Concerns Emerge
Arizona Representative Jeff Weninger’s HB 4001 is being presented as a new tool to crack down on retailers that sell vaping devices and other nicotine products to minors. The bill would create a licensing system for manufacturers and distributors of “alternative nicotine products” and impose fines for sales to people under 21, with penalties reaching USD 10,000 for a fourth violation within 24 months.
Mar.25 by 2FIRSTS.ai
India Tobacco Board urges Finance Minister Nirmala Sitharaman to revisit cigarette duty hike
India Tobacco Board urges Finance Minister Nirmala Sitharaman to revisit cigarette duty hike
The Tobacco Board, under the administrative control of India’s Department of Commerce, has written to Finance Minister Nirmala Sitharaman (Nirmala Sitharaman) flagging the adverse impact of an “unprecedented” increase in cigarette excise duties on the industry and on millions of farmers and workers, and urging a revision of duty rates.
Feb.11 by 2FIRSTS.ai
Reynolds Appeals ITC Defeat in Disposable Vape Section 337 Case to U.S. Federal Circuit
Reynolds Appeals ITC Defeat in Disposable Vape Section 337 Case to U.S. Federal Circuit
On March 13, 2026, R.J. Reynolds and related companies filed an appeal with the U.S. Court of Appeals for the Federal Circuit, seeking review of the U.S. International Trade Commission’s final ruling in the disposable vape Section 337 investigation.
Mar.16 by 2FIRSTS.ai
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11